DocuSign is trading at $70.33, up +8.37%, after beating Q2 estimates and raising full-year guidance.
- Q2 fiscal 2027 revenue was $875.7 million, up 9% year over year; non-GAAP diluted EPS was $1.16 versus the $1.08 estimate.
- Intelligent Agreement Management adoption reached 15.1% of Annual Recurring Revenue.
- Results were scheduled after markets closed on September 3, 2026; broad risk-on trading, including a 1.39% Nasdaq gain, likely added support.